Aziyo Biologics Profit Margin

Aziyo Biologics (AZYO) currently reports a profit margin of -4920.04% as of June 2026. That compares with -290.33% in the prior-year period — down 1594.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Aziyo Biologics's profit margin history and peer comparisons.

Aziyo Biologics's profit margin decreased from -290.33% to -4920.04% — a 1594.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aziyo Biologics's profit margin of -4920.04% is lower than the Healthcare sector average of 13.89%. That is roughly 35513.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Aziyo Biologics's current -4920.04% should be judged against Healthcare norms (sector average: 13.89%) and against AZYO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4920.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Aziyo Biologics, and consider following AZYO for alerts when major investors trade the stock.